
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
about 3 years ago
A New Era of Ethical Leadershipabout 3 years ago
Ahead of the Curve: Pharm Exec Profiles Five Recent Drug Launchesabout 3 years ago
Survival Story: Enhertuabout 3 years ago
Gut Instinct: Rebyotaabout 3 years ago
Delaying Disease Onset: Tzieldabout 3 years ago
New Beginnings: Sunlencaabout 3 years ago
A Heartfelt Solution: Camzyosabout 3 years ago
Fortifying Defenses Pre-Patent Cliffabout 3 years ago
New Product Planning: The Function's Evolution in Pharmaabout 3 years ago
No Rate Relief in Sight for Biotech





